Citigroup
DBTX

Citigroup’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Citigroup’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-291
Closed -$1K – 6065
2022
Q3 		$1K Sell
291
-1,878
-87% -$8.54K ﹤0.01% 5731
2022
Q2 		$9K Buy
2,169
+1,638
+308% +$3.87K ﹤0.01% 5425
2022
Q1 		$2K Sell
531
-220
-29% -$843 ﹤0.01% 6114
2021
Q4 		$3K Buy
+751
New +$5.17K ﹤0.01% 5721
2021
Q2 		– Sell
-474
Closed -$5K – 6495
2021
Q1 		$5K Buy
+474
New +$7.44K ﹤0.01% 5919

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Citigroup's DBTX Position: Q4 2022 in Review

Citigroup sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q4 2022, closing a stake of 291 shares — an estimated $1K sold.

Citigroup first reported a position in DBTX in Q1 2021 and held it in 5 quarters. The position peaked at $9K in Q2 2022. 39 funds tracked by Wall St. Rank hold DBTX as of Q4 2022.

  • Citigroup reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 291 Decibel Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Citigroup first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Citigroup's Decibel Therapeutics, Inc. Common Stock position peaked at $9K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.